Publication Ethics and Malpractice Statement

Publication Ethics and Malpractice Statement

TMP Universal Journal of Advances in Pharmaceutical Sciences is committed to upholding the highest standards of publication ethics and academic integrity. This statement outlines the ethical principles and responsibilities for authors, reviewers, and editors involved in the publication process. It is designed to provide guidance on how to address publication misconduct and to ensure the reliability, accuracy, and transparency of the journal's content.

1. Ethical Responsibilities of Authors

• Originality: Authors must ensure that their work is original and free from plagiarism. Any part of the manuscript that is not original must be properly cited or quoted.
• Authorship: All individuals who have contributed significantly to the research and manuscript preparation should be listed as authors. Authorship should be based on substantial intellectual contribution, and all co-authors should approve the final version of the manuscript before submission.
• Conflicts of Interest: Authors must disclose any financial or personal conflicts of interest that could influence their work. These should be declared at the time of manuscript submission and in the acknowledgments section of the manuscript.
• Data Integrity: Authors must ensure the accuracy and integrity of the data and results presented in the manuscript. Fabrication or falsification of data is strictly prohibited.
• Informed Consent: Authors must ensure that informed consent was obtained from all human subjects or participants involved in the research and that ethical guidelines for human research have been followed.
• Ethical Approval: Authors must provide ethical approval for research involving human or animal subjects. All experiments involving animals should comply with the ethical guidelines of the relevant authorities.
• Concurrent Submissions: Authors should not submit the same manuscript to multiple journals simultaneously. If a manuscript is accepted by another journal, the authors should withdraw their submission from TMP Universal Journal of Advances in Pharmaceutical Sciences immediately.

2. Ethical Responsibilities of Reviewers

• Confidentiality: Reviewers must treat all manuscripts as confidential documents. Manuscripts should not be shared or discussed with anyone other than the editorial team without the authors' permission.
• Impartiality and Objectivity: Reviewers should evaluate manuscripts based on their scientific merit and relevance to the field, not on personal interests or relationships with the authors. Reviews should be unbiased, constructive, and respectful.
• Conflict of Interest: Reviewers should immediately inform the editorial team if they have any conflicts of interest with respect to the manuscript under review. If a conflict is identified, the reviewer may be replaced by another expert.
• Timeliness: Reviewers should provide their feedback within the agreed-upon time frame. If they are unable to complete the review on time, they should notify the editorial office and, if necessary, decline the review assignment.
• Acknowledgment of Sources: Reviewers should alert the editors to any relevant published work that has not been cited by the authors, and they should identify any potential similarities between the manuscript and other published work that may constitute plagiarism.

3. Ethical Responsibilities of Editors

• Decision Making: Editors are responsible for making publication decisions based on the quality, originality, and ethical standards of the manuscript. The decision should be independent of the author's race, gender, nationality, religious beliefs, or institutional affiliation.
• Confidentiality: Editors must ensure that all manuscripts are treated as confidential during the review process. Editors should not disclose any information about the submitted manuscripts to third parties unless authorized by the authors.
• Conflict of Interest: Editors should not use any information or data from submitted manuscripts for personal gain. Editors should disclose any conflicts of interest that could influence their editorial decisions.
• Fair Play: Editors must ensure that all manuscripts are subject to fair and unbiased evaluation, regardless of the authors' backgrounds. Manuscripts should be evaluated based on their scientific merit and relevance to the journal's scope.
• Encouraging Research Integrity: Editors must promote high standards of research integrity. They should encourage authors to adhere to ethical guidelines, disclose conflicts of interest, and follow best practices for research and publication.
• Publication Ethics: Editors are responsible for ensuring that the journal adheres to ethical guidelines, such as those provided by COPE (Committee on Publication Ethics), and addressing any ethical issues that arise during the publication process.

4. Plagiarism and Research Misconduct

• Plagiarism: TMP Universal Journal of Advances in Pharmaceutical Sciences follows a strict policy against plagiarism. Any manuscript found to contain plagiarized material will be rejected, and appropriate steps will be taken in accordance with the journal's plagiarism policy.
• Data Fabrication and Falsification: Authors are expected to provide accurate and honest data. Manuscripts involving fabricated or falsified data will be rejected, and in cases of severe misconduct, the matter will be reported to the authors’ institutions.
• Retraction and Correction: If an article is found to contain significant errors or misconduct after publication, it may be retracted or corrected. The journal follows the COPE guidelines for retraction and correction procedures.

5. Handling Complaints and Allegations

• TMP Universal Journal of Advances in Pharmaceutical Sciences takes all allegations of research misconduct seriously. If an ethical issue arises, such as allegations of plagiarism, data falsification, or authorship disputes, the journal will follow the procedures outlined by COPE to address the matter.
• The editorial team will investigate the issue and communicate with the authors, reviewers, and any relevant parties. If misconduct is confirmed, the manuscript may be rejected, or published articles may be retracted.

6. Publisher's Responsibilities

• The publisher, Twisting Memoirs Publication, ensures that the journal adheres to ethical publishing standards and complies with relevant laws and regulations.
• The publisher will support the editorial team in maintaining editorial independence and preventing any undue influence from authors, institutions, or other external parties.

7. Compliance with Ethical Guidelines

• The journal adheres to the guidelines established by the Committee on Publication Ethics (COPE), ensuring that ethical issues are handled transparently and responsibly.
• The journal also follows best practices for handling ethics in publishing, ensuring that all stakeholders, including authors, reviewers, and editors, are informed and educated about their responsibilities.